UniProt ID | ATP5J_HUMAN | |
---|---|---|
UniProt AC | P18859 | |
Protein Name | ATP synthase-coupling factor 6, mitochondrial | |
Gene Name | ATP5J | |
Organism | Homo sapiens (Human). | |
Sequence Length | 108 | |
Subcellular Localization | Mitochondrion. Mitochondrion inner membrane. | |
Protein Description | Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. Also involved in the restoration of oligomycin-sensitive ATPase activity to depleted F1-F0 complexes.. | |
Protein Sequence | MILQRLFRFSSVIRSAVSVHLRRNIGVTAVAFNKELDPIQKLFVDKIREYKSKRQTSGGPVDASSEYQQELERELFKLKQMFGNADMNTFPTFKFEDPKFEVIEKPQA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
41 | Ubiquitination | KELDPIQKLFVDKIR CCCCHHHHHHHHHHH | 44.61 | 21890473 | |
41 | Acetylation | KELDPIQKLFVDKIR CCCCHHHHHHHHHHH | 44.61 | 19608861 | |
46 | Acetylation | IQKLFVDKIREYKSK HHHHHHHHHHHHHHH | 38.06 | 19608861 | |
46 | Ubiquitination | IQKLFVDKIREYKSK HHHHHHHHHHHHHHH | 38.06 | 21890473 | |
46 | Succinylation | IQKLFVDKIREYKSK HHHHHHHHHHHHHHH | 38.06 | 27452117 | |
46 | 2-Hydroxyisobutyrylation | IQKLFVDKIREYKSK HHHHHHHHHHHHHHH | 38.06 | - | |
49 | Ubiquitination | LFVDKIREYKSKRQT HHHHHHHHHHHHCCC | 61.87 | 19608861 | |
49 | Acetylation | LFVDKIREYKSKRQT HHHHHHHHHHHHCCC | 61.87 | 19608861 | |
51 | Succinylation | VDKIREYKSKRQTSG HHHHHHHHHHCCCCC | 44.76 | 23954790 | |
54 | Ubiquitination | IREYKSKRQTSGGPV HHHHHHHCCCCCCCC | 52.69 | 19608861 | |
54 | Acetylation | IREYKSKRQTSGGPV HHHHHHHCCCCCCCC | 52.69 | 19608861 | |
56 | Phosphorylation | EYKSKRQTSGGPVDA HHHHHCCCCCCCCCC | 33.11 | 30266825 | |
57 | Phosphorylation | YKSKRQTSGGPVDAS HHHHCCCCCCCCCCC | 33.15 | 30266825 | |
64 | Phosphorylation | SGGPVDASSEYQQEL CCCCCCCCHHHHHHH | 21.17 | 26657352 | |
65 | Phosphorylation | GGPVDASSEYQQELE CCCCCCCHHHHHHHH | 41.88 | 30266825 | |
67 | Phosphorylation | PVDASSEYQQELERE CCCCCHHHHHHHHHH | 19.90 | 28450419 | |
72 | Phosphorylation | SEYQQELERELFKLK HHHHHHHHHHHHHHH | 43.27 | 24719451 | |
73 | Phosphorylation | EYQQELERELFKLKQ HHHHHHHHHHHHHHH | 59.55 | 27251275 | |
79 | Malonylation | ERELFKLKQMFGNAD HHHHHHHHHHHCCCC | 40.06 | 26320211 | |
79 | Acetylation | ERELFKLKQMFGNAD HHHHHHHHHHHCCCC | 40.06 | 23236377 | |
79 | Ubiquitination | ERELFKLKQMFGNAD HHHHHHHHHHHCCCC | 40.06 | 21890473 | |
94 | Succinylation | MNTFPTFKFEDPKFE CCCCCCCCCCCCCCE | 50.77 | - | |
94 | Acetylation | MNTFPTFKFEDPKFE CCCCCCCCCCCCCCE | 50.77 | 26822725 | |
94 | Succinylation | MNTFPTFKFEDPKFE CCCCCCCCCCCCCCE | 50.77 | - | |
94 | Ubiquitination | MNTFPTFKFEDPKFE CCCCCCCCCCCCCCE | 50.77 | - | |
99 | Succinylation | TFKFEDPKFEVIEKP CCCCCCCCCEEEECC | 67.49 | 23954790 | |
99 | Acetylation | TFKFEDPKFEVIEKP CCCCCCCCCEEEECC | 67.49 | 19608861 | |
99 | Succinylation | TFKFEDPKFEVIEKP CCCCCCCCCEEEECC | 67.49 | - | |
99 | Ubiquitination | TFKFEDPKFEVIEKP CCCCCCCCCEEEECC | 67.49 | 21890473 | |
105 | Acetylation | PKFEVIEKPQA---- CCCEEEECCCC---- | 31.16 | 19608861 | |
105 | Malonylation | PKFEVIEKPQA---- CCCEEEECCCC---- | 31.16 | 26320211 | |
107 | Acetylation | FEVIEKPQA------ CEEEECCCC------ | 71.43 | 19608861 | |
107 | Ubiquitination | FEVIEKPQA------ CEEEECCCC------ | 71.43 | 19608861 | |
113 | Acetylation | PQA------------ CCC------------ | 19608861 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATP5J_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATP5J_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATP5J_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ATPK_HUMAN | ATP5J2 | physical | 22939629 | |
ATPO_HUMAN | ATP5O | physical | 22939629 | |
QCR2_HUMAN | UQCRC2 | physical | 22939629 | |
COA6_HUMAN | COA6 | physical | 22939629 | |
PARK7_HUMAN | PARK7 | physical | 22939629 | |
ATP5I_HUMAN | ATP5I | physical | 26344197 | |
ATPO_HUMAN | ATP5O | physical | 26344197 | |
FABP5_HUMAN | FABP5 | physical | 26344197 | |
GSTO1_HUMAN | GSTO1 | physical | 26344197 | |
PRDX3_HUMAN | PRDX3 | physical | 26344197 | |
UCRI_HUMAN | UQCRFS1 | physical | 26344197 | |
ATPB_HUMAN | ATP5B | physical | 16230521 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-41; LYS-46; LYS-99 ANDLYS-105, AND MASS SPECTROMETRY. |